Liao et al. (31) studied 5,778 CAD patients treated with statins and undergoing PCI, discovering that high residual inflammation and cholesterol risk, assessed by high-sensitivity C-reactive protein and RC were closely related to an increased risk of ischemic events, cardiovascular death, and all-cause mortality. The gene discussed is CRP; the disease is coronary artery disorder.